- Home
- NXT vs PEN Comparison
NXT vs PEN Comparison
Compare NXT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXT
- PEN
- Stock Information
- Founded
- NXT 2013
- PEN 2004
- Country
- NXT United States
- PEN United States
- Employees
- NXT N/A
- PEN N/A
- Industry
- NXT Semiconductors
- PEN Medical/Dental Instruments
- Sector
- NXT Technology
- PEN Health Care
- Exchange
- NXT Nasdaq
- PEN Nasdaq
- Market Cap
- NXT 10.2B
- PEN 9.9B
- IPO Year
- NXT 2023
- PEN 2015
- Fundamental
- Price
- NXT $76.97
- PEN $246.92
- Analyst Decision
- NXT Buy
- PEN Strong Buy
- Analyst Count
- NXT 19
- PEN 16
- Target Price
- NXT $65.58
- PEN $301.93
- AVG Volume (30 Days)
- NXT 2.0M
- PEN 406.5K
- Earning Date
- NXT 10-23-2025
- PEN 10-29-2025
- Dividend Yield
- NXT N/A
- PEN N/A
- EPS Growth
- NXT N/A
- PEN 916.05
- EPS
- NXT 3.67
- PEN 3.74
- Revenue
- NXT $3,103,529,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- NXT $15.37
- PEN $15.52
- Revenue Next Year
- NXT $9.58
- PEN $14.20
- P/E Ratio
- NXT $21.13
- PEN $66.61
- Revenue Growth
- NXT 13.26
- PEN 12.92
- 52 Week Low
- NXT $30.93
- PEN $190.08
- 52 Week High
- NXT $80.83
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- NXT 61.83
- PEN 39.91
- Support Level
- NXT $74.91
- PEN $242.41
- Resistance Level
- NXT $80.82
- PEN $260.89
- Average True Range (ATR)
- NXT 3.41
- PEN 7.31
- MACD
- NXT 0.26
- PEN -1.10
- Stochastic Oscillator
- NXT 70.74
- PEN 19.70
About NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.